Agata K.
- Country
- Poland
- Department
- n/a
Research Overview
- Efficacy and Safety of Barzolvolimab in Patients with Chronic Spontaneous Urticaria Symptomatic Despite H1 Antihistamine Treatment: A Phase 3 Randomized, Placebo-Controlled Study
- A Randomized, Double-Blind, Placebo-Controlled Trial of Orforglipron (LY3502970) for BMI Reduction in Adolescents with Obesity or Overweight-Related Comorbidities
Data & Insights
Has run more than one trial at 1 of 102 partner sites.
Specializations
Dermatological Conditions
This investigator specializes in the treatment and research of chronic spontaneous urticaria, a challenging dermatological condition characterized by recurring hives and itching.
- Urticaria Management
- Autoimmune Skin Disorders
- Clinical Assessment Methods
The investigator's work focuses on evaluating novel therapeutic approaches for patients with treatment-resistant urticaria symptoms.
Immunological Research
Expertise centers on immunological mechanisms underlying chronic skin conditions, with particular attention to immune system modulation in urticaria treatment.
- Immune Response Evaluation
- Biological Therapeutics
- Treatment Resistance
The research encompasses innovative therapeutic strategies targeting specific immune pathways in chronic urticaria.
Clinical Assessment
Specializes in implementing and analyzing clinical measurement tools such as the weekly urticaria activity score (UAS7) for evaluating treatment efficacy.
- Disease Activity Monitoring
- Treatment Response Assessment
- Patient Outcome Measures
The investigator utilizes standardized assessment methods to evaluate therapeutic interventions in chronic urticaria.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.